Sec Form 4/A Filing - RA CAPITAL MANAGEMENT, LLC @ ACHILLION PHARMACEUTICALS INC - 2014-09-10

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4/A
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
RA CAPITAL MANAGEMENT, LLC
2. Issuer Name and Ticker or Trading Symbol
ACHILLION PHARMACEUTICALS INC [ ACHN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O RA CAPITAL MANAGEMENT, LLC, 20 PARK PLAZA, SUITE 1200
3. Date of Earliest Transaction (MM/DD/YY)
09/10/2014
(Street)
BOSTON, MA02116
4. If Amendment, Date Original Filed (MM/DD/YY)
09/12/2014
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 par value 09/10/2014 S 8,600 ( 1 ) D $ 12.7259 14,695,762 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/10/2014 S 49,057 ( 1 ) D $ 12.6908 14,646,705 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/10/2014 S 273,017 ( 2 ) D $ 12.7013 14,373,688 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/10/2014 S 69,833 ( 3 ) D $ 12.6288 14,303,855 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/10/2014 S 121,943 ( 4 ) D $ 12.6098 14,181,912 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/11/2014 S 184,643 ( 5 ) D $ 12.4132 13,997,269 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/11/2014 S 83,560 ( 6 ) D $ 12.6238 13,913,709 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/11/2014 S 531,352 ( 7 ) D $ 12.3053 13,382,357 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/11/2014 S 115,000 ( 8 ) D $ 12.3348 13,267,357 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/11/2014 S 17,357 ( 9 ) D $ 12.3248 13,250,000 I See Footnotes ( 12 ) ( 13 )
Common Stock, $0.001 par value 09/11/2014 S 250,000 ( 10 ) D $ 12.35 13,000,000 ( 11 ) I See Footnotes ( 12 ) ( 13 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
RA CAPITAL MANAGEMENT, LLC
C/O RA CAPITAL MANAGEMENT, LLC
20 PARK PLAZA, SUITE 1200
BOSTON, MA02116
X
RA Capital Healthcare Fund LP
C/O RA CAPITAL MANAGEMENT, LLC
20 PARK PLAZA, SUITE 1200
BOSTON, MA02116
X
Kolchinsky Peter
C/O RA CAPITAL MANAGEMENT, LLC
20 PARK PLAZA, SUITE 1200
BOSTON, MA02116
X
Signatures
Peter Kolchinsky, Manager of RA Capital Management, LLC 09/12/2014
Signature of Reporting Person Date
Peter Kolchinsky, individually 09/12/2014
Signature of Reporting Person Date
Peter Kolchinsky, Manager of RA Capital Management, LLC, the General Partner of RA Capital Healthcare Fund, L.P. 09/12/2014
Signature of Reporting Person Date
Explanation of Responses:
( 1 )All such shares were sold by RA Capital Healthcare Fund, L.P. (the "Fund").
( 2 )The securities sold include 223,874 shares for the Fund and 49,143 shares for an account owned by Blackwell Partners, LLC (the "Blackwell Account").
( 3 )The securities sold include 57,263 shares for the Fund and 12,570 shares for an account owned by the Blackwell Account.
( 4 )The securities sold include 99,993 shares for the Fund and 21,950 shares for an account owned by the Blackwell Account.
( 5 )The securities sold include 151,407 shares for the Fund and 33,236 shares for an account owned by the Blackwell Account.
( 6 )The securities sold include 68,519 shares for the Fund and 15,041 shares for an account owned by the Blackwell Account.
( 7 )The securities sold include 435,709 shares for the Fund and 95,643 shares for an account owned by the Blackwell Account.
( 8 )The securities sold include 94,299 shares for the Fund and 20,701 shares for an account owned by the Blackwell Account.
( 9 )The securities sold include 14,231 shares for the Fund and 3,126 shares for an account owned by the Blackwell Account.
( 10 )The securities sold include 205,003 shares for the Fund and 44,997 shares for an account owned by the Blackwell Account.
( 11 )Following the transactions set forth on Tabl e I above, 9,982,562 shares are held by the Fund, and 3,017,438 shares are held in the Blackwell Account.
( 12 )RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Blackwell Account. Peter Kolchinsky is the sole manager of the Adviser. In their respective capacities, each of Mr. Kolchinsky and the Adviser may be deemed to beneficially own the reported securities.
( 13 )Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interests therein. The filing of this Form 4 shall not be construed as an admission that Mr. Kolchinsky or the Adviser is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of securities reported herein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.